Pyruvate dehydrogenase kinase 4 expression is synergistically induced by AMP-activated protein kinase and fatty acids

Cellular and Molecular Life Sciences

Volumn 66, Issue 7, 2009, Pages 1283-1294

  Houten, S M ^a   Chegary, M ^a   Te Brinke, H ^a   Wijnen, W J ^b   Glatz, J F C ^b   Luiken, J J F P ^b   Wijburg, F A ^a   Wanders, R J A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

AMP activated protein kinase; Fatty acids; Glucose metabolism; Hypoxia; Pyruvate dehydrogenase; Pyruvate dehydrogenase kinase 4

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ENERGY; CONTROLLED STUDY; ENZYME ACTIVATION; EVIDENCE BASED PRACTICE; GLUCOSE OXIDATION; HYPOXIA; MODULATION; NONHUMAN; PEROXISOME; PROTEIN EXPRESSION; RAT;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL HYPOXIA; CELLS, CULTURED; ENERGY METABOLISM; ENZYME ACTIVATION; FATTY ACIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; LIGANDS; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROTEIN KINASES; RATS;

EID: 63449090525     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-009-9066-x     Document Type: Article

References (45)

1. Randle, P. J., Garland, P. B., Hales, C. N. and Newsholme, E. A. (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
2. Bowker-Kinley, M. M., Davis, W. I., Wu, P., Harris, R. A. and Popov, K. M. (1998) Evidence for existence of tissue-specific regulation, of the mammalian pyruvate dehydrogenase complex. Biochem. J. 329 ( Pt 1), 191-196.
3. Patel, M. S. and Korotchkina, L. G. (2006) Regulation of the pyruvate dehydrogenase complex. Biochem. Soc. Trans. 34, 217-222.
4. Roche, T. E. and Hiromasa, Y. (2007) Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell. Mol. Life Sci. 64, 830-849.
5. Sugden, M. C. and Holness, M. J. (2006) Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch. Physiol. Biochem. 112, 139-149.
6. Kim, J. W., Tchernyshyov, I., Semenza, G. L. and Dang, C. V. (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3, 177-185.
7. Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L. and Denko, N. C. (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187-197.
8. Araki, M. and Motojima, K. (2006) Identification of ERRalpha as a specific partner of PGC-1alpha for the activation of PDK4 gene expression in muscle. FEBS J. 273, 1669-1680.
9. Huang, B., Wu, P., Bowker-Kinley, M. M. and Harris, R. A. (2002) Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes 51, 276-283.
10. Zhang, Y., Ma, K., Sadana, P., Chowdhury, F., Gaillard, S., Wang, F., McDonnell, D. P., Unterman, T. G., Elam, M. B. and Park, E. A. (2006) Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J. Biol. Chem. 281, 39897-39906.
11. Kahn, B. B., Alquier, T., Carling, D. and Hardie, D. G. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25.
12. Stein, S. C., Woods, A., Jones, N. A., Davison, M. D. and Carling, D. (2000) The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 345 Pt 3, 437-443.
13. Luiken, 11, van Nieuwenhoven, F. A., America, G., van der Vusse, G. J. and Glatz, J. F. (1997) Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins. J. Lipid Res. 38, 745-758.
14. Chegary, M., te Brinke, H., Doolaard, M., IJlst, L., Wijburg, F. A., Wanders, R. J. and Houten, S. M. (2008) Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation. Mol. Genet. Metab 93, 403-410.
15. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A. and Evans, R. M. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774.
16. Sambrook,J. and Russell,D. W. (2001) Molecular Cloning: a Laboratory Manual, Cold Spring Harbor Laboratory Press.
17. Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T and Gonzalez, F. J. (1998) Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 273, 5678-5684.
18. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G. and Wahli, W. (1992) Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887.
19. Gulick, T., Cresci, S., Caira, T., Moore, D. D. and Kelly, D. P. (1994) The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. U.S.A 91, 11012-11016.
20. Napal, L., Marrero, P. F. and Haro, D. (2005) An intronic peroxisome proliferator-activated receptor-binding sequence mediates fatty acid induction of the human carnitine palmitoyltransferase 1A. J. Mol. Biol. 354, 751-759.
21. Osumi, T., Wen, J. K. and Hashimoto, T. (1991) Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene. Biochem. Biophys. Res. Commun. 175, 866-871.
22. Tugwood, J.D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L. and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11, 433-439.
23. Stavinoha, M. A., RaySpellicy, J. W., Essop, M. F., Graveleau, C., Abel, E. D., Hart-Sailors, M. L., Mersmann, H. J., Bray, M. S. and Young, M. E. (2004) Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator- activated receptor-alpha-regulated gene in cardiac and skeletal muscle. Am. J. Physiol Endocrinol. Metab 287, E888-E895.
24. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J. and Moller, D. E. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest 108, 1167-1174.
25. Stoppani, J., Hildebrandt, A. L., Sakamoto, K., Cameron-Smith, D., Goodyear, L. J. and Neufer, P. D. (2002) AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283, E1239-E1248.
26. Poirier, H., Braissant, O., Niot, I., Wahli, W. and Besnard, P. (1997) 9-cis-retinoic acid enhances fatty acid-induced expression of the liver fatty acid-binding protein gene. FEBS Lett. 412, 480-484.
27. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B. and Hue, L. (2006) 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874.
28. Guigas, B., Taleux, N., Foretz, M., Detaille, D., Andreelli, F., Viollet, B. and Hue, L. (2007) AMP-activated protein kinase-independent inhibition, of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem. J. 404, 499-507.
29. Eaton, S. (2002) Control of mitochondrial beta-oxidation flux. Prog. Lipid Res. 41, 197-239.
30. Forman, B. M., Chen, J. and Evans, R. M. (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. U.S.A 94, 4312-4317.
31. Mandard, S., Muller, M. and Kersten, S. (2004) Peroxisome proliferator-activated receptor alpha target genes. Cell Mol. Life Sci. 61, 393-416.
32. Abbot, E. L., McCormack, J. G., Reynet, C., Hassall, D. G., Buchan, K. W and Yeaman, S. J. (2005) Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells. FEBS J. 272, 3004-3014.
33. Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Raito, M., Auwerx, J., Yanagisawa, M., Kodama, T. and Sakai, J. (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in. skeletal muscle and attenuates metabolic syndrome. Proc. Rati. Acad. Sci. USA 100, 15924-9.
34. Wu, P., Peters, J.M. and Harris, R. A. (2001) Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem. Biophys. Res. Commun. 287, 391-396.
35. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., Kang, H., Shaw, R. J. and Evans, R. M. (2008) AMPK and PPARdelta agonists are exercise mimetics. Cell. 134, 405-415.
36. Degenhardt, T., Saramaki, A., Mahnen, M., Rieck, M., Vaisanen, S., Huotari, A., Herzig, K. H., Muller, R. and Carlberg, C. (2007) Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta. J. Mol. Biol. 372, 341-355.
37. Burns, K. A. and Vanden Heuvel, J. P. (2007) Modulation of PPAR activity via phosphorylation. Biochim. Biophys. Acta 1771, 952-960.
38. Yoon, M. J., Lee, G. Y., Chung, J. J., Ahn, Y. H., Hong, S. H. and Kim, J. B. (2006) Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55, 2562-2570.
39. Lee, W. J., Kim, M., Park, H. S., Kim, H. S., Jeon, M. J., Oh, K. S., Koh, E. H., Won, J. C., Kim, M. S., Oh, G. T., Yoon, M., Lee, K. U. and Park, J. Y. (2006) AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1, Biochem. Biophys. Res. Commun. 340, 291-295.
40. Luiken, J. J., Coort, S. L., Willems, J., Coumans, W. A., Bonen, A., van der Vusse, G. J. and Glatz, J. F. (2003) Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52, 1627-1634.
41. Kong, S. W., Bodyak, N., Yue, P., Liu, Z., Brown, J., Izumo, S. and Kang, P. M. (2005) Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol. Genomics 21, 34-42.
42. Arikawa, E., Ma, R. C., Isshiki, K., Luptak, I., He, Z., Yasuda, Y., Maeno, Y., Patti, M. E., Weir, G. C., Harris, R. A., Zammit, V. A., Tian, R. and King, G. L. (2007) Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats. Diabetes 56, 1410-1420.
43. Glyn-Jones, S., Song, S., Black, M. A., Phillips, A. R., Choong, S. Y. and Cooper, G. J. (2007) Transcriptomic analysis of the cardiac left ventricle in a rodent model of diabetic cardiomyopathy: molecular snapshot of a severe myocardial, disease. Physiol. Genomics 28, 284-293.
44. Herrema, H., Derks, T. G., van Dijk, T. H., Bloks, V. W., Gerding, A., Havinga, R., Tietge, U. J., Müller, M., Smit, G. P., Kuipers, E and Reijngoud, D. J. (2008) Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice. Hepatology 47, 1894-1904.
45. Horiuchi, M., Kobayashi, K., Masuda, M., Terazono, H. and Saheki, T. (1999) Pyruvate dehydrogenase kinase 4 mRRA is increased in the hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice. Biofactors 10, 301-309.